Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Massive Proteinuria which Rapidly Resolved after Discontinuation of Regorafenib
View through CrossRef
Abstract: Regorafenib is treatment option of cancers. It is associated with several adverse effects, including proteinuria. We report a massive proteinuria associated with regorafenib which resolved quickly after discontinuation of the drug. A 63 year old male presented with diarrhea and bilateral swallowing of legs. In urinanalysis, 18.5 g/day of proteinuria was detected. All symptoms, including proteinuria, resolved after discontinuation of regorafenib. Despite cessation of regorafenib treatment is advised in case of proteinuria, we suggest that regorafenib associated proteinuria could be rapidly resolved after discontinuation of the drug.
Title: Massive Proteinuria which Rapidly Resolved after Discontinuation of Regorafenib
Description:
Abstract: Regorafenib is treatment option of cancers.
It is associated with several adverse effects, including proteinuria.
We report a massive proteinuria associated with regorafenib which resolved quickly after discontinuation of the drug.
A 63 year old male presented with diarrhea and bilateral swallowing of legs.
In urinanalysis, 18.
5 g/day of proteinuria was detected.
All symptoms, including proteinuria, resolved after discontinuation of regorafenib.
Despite cessation of regorafenib treatment is advised in case of proteinuria, we suggest that regorafenib associated proteinuria could be rapidly resolved after discontinuation of the drug.
Related Results
HOW TO INTERPRET URINARY PROTEINURIA AS A MARKER OF HYPERTENSIVE NEPHROPATHY?
HOW TO INTERPRET URINARY PROTEINURIA AS A MARKER OF HYPERTENSIVE NEPHROPATHY?
Objective:
Proteinuria may be the first sign of underlying nephropathy. It is pathological when the value is higher than 0.15 g/24h.
The gold standard of qu...
Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the Meeting of the European Society for Medical Oncology (ESMO) Congress 2016
Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the Meeting of the European Society for Medical Oncology (ESMO) Congress 2016
The European Society for Medical Oncology (ESMO) Congress was held in Copenhagen, Denmark from 7th–11th October 2016. The use of the promiscuous multikinase inhibitor regorafenib (...
MO655PROTEINURIA DECREASE AFTER SGLT2I : WHAT CAN WE EXPECT?
MO655PROTEINURIA DECREASE AFTER SGLT2I : WHAT CAN WE EXPECT?
Abstract
Background and Aims
The effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in reducing proteinuria secondary ...
FREKUENSI PROTEINURIA PADA PENDERITA LUPUS ERITEMATOSUS SISTEMIK (LES)
FREKUENSI PROTEINURIA PADA PENDERITA LUPUS ERITEMATOSUS SISTEMIK (LES)
ABSTRAK
Latar Belakang Lupus Eritematosus Sistemik (LES) merupakan penyakit autoimun multisistem yang mengakibatkan kerusakan organ,jaringan dan sel mediasi karena ko...
Regorafenib in Bone Sarcoma: A Systematic Review and Meta-Analysis of Its Effectiveness and Safety in Cancer Treatment
Regorafenib in Bone Sarcoma: A Systematic Review and Meta-Analysis of Its Effectiveness and Safety in Cancer Treatment
Abstract
Objectives
Bone sarcomas are aggressive malignancies with limited treatment options in advanced stages. Regorafenib, a...
Do discontinuation symptoms predict depression relapse after antidepressant cessation?
Do discontinuation symptoms predict depression relapse after antidepressant cessation?
Background: Discontinuing antidepressants after recovering from a depressive episode is associated with a risk for two events: discontinuation symptoms and relapse. Little is known...
MO205: The Outcome of Patients Without Nephrotic Syndrome (NS) is Not Different From Patients With NS, WHO Were Diagnosed as Minimal Change Lesion
MO205: The Outcome of Patients Without Nephrotic Syndrome (NS) is Not Different From Patients With NS, WHO Were Diagnosed as Minimal Change Lesion
Abstract
BACKGROUND AND AIMS
Minimal change lesion (MCD) accounts for 10–15% of adult patients with nephrotic syndrome and is ch...
Proteinuria Pasien Diabetes Melitus dan Obesitas Poli Penyakit Dalam RS Ibnu Sina Makassar
Proteinuria Pasien Diabetes Melitus dan Obesitas Poli Penyakit Dalam RS Ibnu Sina Makassar
Background: The prevalence of diabetes mellitus in the world has increased which is certainly accompanied by a rapid increase in the incidence of its chronic complications like kid...